These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Cyclooxygenase-2 inhibitors: a new approach to the therapy of ocular inflammation. Masferrer JL; Kulkarni PS Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S35-40. PubMed ID: 9154274 [TBL] [Abstract][Full Text] [Related]
47. The Role of Celecoxib as a Potential Inhibitor in the Treatment of Inflammatory Diseases - A Review. Cruz JV; Rosa JMC; Kimani NM; Giuliatti S; Dos Santos CBR Curr Med Chem; 2022; 29(17):3028-3049. PubMed ID: 34514981 [TBL] [Abstract][Full Text] [Related]
48. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Clària J; Romano M Curr Pharm Des; 2005; 11(26):3431-47. PubMed ID: 16250846 [TBL] [Abstract][Full Text] [Related]
49. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent. Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617 [TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. Famaey JP Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063 [TBL] [Abstract][Full Text] [Related]
51. [Pharmacology of cyclooxygenase 2 inhibition]. Beubler E Wien Med Wochenschr; 2003; 153(5-6):95-9. PubMed ID: 12705061 [TBL] [Abstract][Full Text] [Related]
52. Selective cyclooxygenase inhibitors: current status. Nandakishore R; Yalavarthi PR; Kiran YR; Rajapranathi M Curr Drug Discov Technol; 2014 Jun; 11(2):127-32. PubMed ID: 24467591 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818 [TBL] [Abstract][Full Text] [Related]
54. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Willoughby DA; Moore AR; Colville-Nash PR Lancet; 2000 Feb; 355(9204):646-8. PubMed ID: 10696997 [TBL] [Abstract][Full Text] [Related]
55. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954 [TBL] [Abstract][Full Text] [Related]